Literature DB >> 32285915

Typical takotsubo syndrome triggered by SARS-CoV-2 infection.

Philippe Meyer1, Sophie Degrauwe1, Christian Van Delden2, Jelena-Rima Ghadri3, Christian Templin3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32285915      PMCID: PMC7184501          DOI: 10.1093/eurheartj/ehaa306

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
Takotsubo syndrome (TTS) is an important differential diagnosis of myocardial injury, which may play a significant role in the COVID-19 pandemic. This report describes a typical case of TTS triggered by SARS-CoV-2 infection. An 83-year-old lady treated for chronic hypertension was hospitalized for acute chest pain on 18 March 2020, 21 days after the COVID-19 outbreak started in Geneva, Switzerland. She described a 5/10 oppressive mediosternal non-radiating chest discomfort associated with mild breathlessness and dry cough since 15 March. Physical examination was unremarkable. ECG (Panel A) showed <1 mm ST-segment elevation in all precordial leads with deep T-wave inversions. High-sensitive cardiac troponin T was elevated at 1142 ng/L (<14 ng/L). Chest X-ray did not detect any pulmonary opacity. Echocardiography revealed typical left ventricular apical ballooning with hyperkinetic basal segments. Coronary angiography showed non-significant lesions (Panel B) with a typical takotsubo syndrome (TTS) image on ventriculography (Panel C). At day 3, the patient started developing fever, showing increasing biological signs of inflammation, and clear bilateral lung X-ray opacities (Panel D). Nasopharyngeal swab was negative for SARS-CoV-2, but the initial positive immunoglobin A and negative immunoglobulin G serology pattern proved acute infection. The patient recovered progressively on conventional heart failure medication without the need for oxygen/ventilation, and echocardiography showed only mild residual apical hypokinesis on the day of discharge (day 10). This is to our knowledge the first case of TTS described in the COVID-19 pandemic. The huge emotional stress at the population level and respiratory infections caused by COVID-19 may represent potential triggers in this context. Myocardial injury, frequently reported in patients with COVID-19, is usually attributed to sepsis and/or hypoxaemia and/or underlying coronary artery disease, as well as myocarditis. We believe that TTS may also play a significant role in the COVID-19 pandemic.

We would like to thank Nicolas Johner, MD who helped in designing the figure. Authors’ contributions: all authors participated in writing and approved the final manuscript. Written consent for publication was obtained from the patient.
  63 in total

Review 1.  Takotsubo syndrome: the broken-heart syndrome.

Authors:  Rienzi Díaz-Navarro
Journal:  Br J Cardiol       Date:  2021-03-09

2.  Co-infection of human immunodeficiency virus, herpes simplex virus-2 and SARS-CoV-2 in a patient with false-negative real-time polymerase chain reaction results.

Authors:  Abdulrahman Alharthy; Fahad Faqihi; AlFateh Noor; Ziad A Memish; Dimitrios Karakitsos
Journal:  Singapore Med J       Date:  2020-11-30       Impact factor: 3.331

3.  Global evaluation of echocardiography in patients with COVID-19.

Authors:  Marc R Dweck; Anda Bularga; Rebecca T Hahn; Rong Bing; Kuan Ken Lee; Andrew R Chapman; Audrey White; Giovanni Di Salvo; Leyla Elif Sade; Keith Pearce; David E Newby; Bogdan A Popescu; Erwan Donal; Bernard Cosyns; Thor Edvardsen; Nicholas L Mills; Kristina Haugaa
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-09-01       Impact factor: 6.875

Review 4.  Cardiovascular Complications in Major 21st Century Viral Epidemics and Pandemics: an Insight into COVID-19.

Authors:  Muzna Hussain; Patrick Collier; Rohit Moudgil
Journal:  Curr Cardiol Rev       Date:  2021

5.  Case report of Takotsubo syndrome following seizures in a patient with pyruvate carboxylase deficiency.

Authors:  Nikhil Sahdev; Onyedikachi Oji; Aswin Babu; Smita Dutta Roy
Journal:  Eur Heart J Case Rep       Date:  2021-03-04

6.  Cardiovascular impact of COVID-19: an array of presentations.

Authors:  Hira Maab; Faryal Mustafa; Syeda Javeria Shabbir
Journal:  Acta Biomed       Date:  2021-05-12

Review 7.  Getting to the Heart of the Matter: Myocardial Injury, Coagulopathy, and Other Potential Cardiovascular Implications of COVID-19.

Authors:  Aaron Schmid; Marija Petrovic; Kavya Akella; Anisha Pareddy; Sumathilatha Sakthi Velavan
Journal:  Int J Vasc Med       Date:  2021-04-22

8.  Association of coronary calcification with prognosis of Covid-19 patients without known heart disease.

Authors:  R Y Possari; H J Andrade-Gomes; V C Mello; E A Galdeano; L F Aguiar-Filho; M S Bittencourt; E V Ponte; L R Bertoche; L R S Caio; J D Rodrigues; F B Alcantara; M A C Freitas; J C G C Sarinho; N K Cervigne; W M Rodrigues; I Aprahamian
Journal:  Braz J Med Biol Res       Date:  2021-12-03       Impact factor: 2.590

9.  COVID-19 and Cardiomyopathy: A Systematic Review.

Authors:  Fatemeh Omidi; Bahareh Hajikhani; Seyyedeh Neda Kazemi; Ardeshir Tajbakhsh; Sajedeh Riazi; Mehdi Mirsaeidi; Ali Ansari; Masoud Ghanbari Boroujeni; Farima Khalili; Sara Hadadi; Mohammad Javad Nasiri
Journal:  Front Cardiovasc Med       Date:  2021-06-17

Review 10.  Takotsubo Syndrome-Is There a Need for CMR?

Authors:  Philipp-Johannes Jensch; Thomas Stiermaier; Ingo Eitel
Journal:  Curr Heart Fail Rep       Date:  2021-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.